Evidence map›Paper›PMID 28793638›Full record

ReviewMaterials (Basel, Switzerland)2015

Green Synthesis of Metallic Nanoparticles via Biological Entities.

Monaliben Shah, Derek Fawcett, Shashi Sharma, Suraj Kumar Tripathy, Gérrard Eddy Jai Poinern

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Materials (Basel, Switzerland), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 224 papers.

0numbers the graph read from it
0cells of the map it votes in
224citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

224 citing papers in PubMed.

  1. Article
  2. Article
  3. Antimicrobial synergism of silver and zinc oxide nanoparticles with antibiotics against clinical isolate of Cutibacterium acnes.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Metal oxide nanoparticles: emerging stars in biomedical application.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026
    Review
  12. Current pharmaceutical biotechnology · 2026
    Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

164 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Monaliben ShahMurdoch Applied Nanotechnology Research Group, Faculty of Minerals and Energy, School of Engineering and Energy, Murdoch University, Murdoch WA 6150, Australia. monalinikunj.shah@gmail.com.
Derek FawcettMurdoch Applied Nanotechnology Research Group, Faculty of Minerals and Energy, School of Engineering and Energy, Murdoch University, Murdoch WA 6150, Australia. D.Fawcett@murdoch.edu.au.
Shashi SharmaBiosecurity and Food Security Academy, School of Veterinary and Life Sciences, Agricultural Sciences Murdoch University, Murdoch WA 6150, Australia. Sharma@murdoch.edu.au.
Suraj Kumar TripathySchool of Biotechnology, School of Applied Sciences, KIIT University, Campus-11, Bhubaneswar 751024, Odisha, India. suraj.tripathy@kiitbiotech.ac.in.
Gérrard Eddy Jai PoinernMurdoch Applied Nanotechnology Research Group, Faculty of Minerals and Energy, School of Engineering and Energy, Murdoch University, Murdoch WA 6150, Australia. g.poinern@murdoch.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanotechnology is the creation, manipulation and use of materials at the nanometre size scale (1 to 100 nm). At this size scale there are significant differences in many material properties that are normally not seen in the same materials at larger scales. Although nanoscale materials can be produced using a variety of traditional physical and chemical processes, it is now possible to biologically synthesize materials via environment-friendly green chemistry based techniques. In recent years, the convergence between nanotechnology and biology has created the new field of nanobiotechnology that incorporates the use of biological entities such as actinomycetes algae, bacteria, fungi, viruses, yeasts, and plants in a number of biochemical and biophysical processes. The biological synthesis via nanobiotechnology processes have a significant potential to boost nanoparticles production without the use of harsh, toxic, and expensive chemicals commonly used in conventional physical and chemical processes. The aim of this review is to provide an overview of recent trends in synthesizing nanoparticles via biological entities and their potential applications.

Indexed as

biological synthesisgreen chemistrynanoparticles

Identifiers

PMID28793638
PMCPMC5458933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.